🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/07/2005 42,27 42,88 41,20 42,81 +1,66% 3,97% 418.700
01/07/2005 42,14 42,52 41,68 42,11 +0,12% 1,99% 286.100
30/06/2005 41,93 42,65 41,93 42,06 +0,33% 1,72% 270.300
29/06/2005 41,67 42,39 41,67 41,92 +0,72% 1,73% 354.000
28/06/2005 41,89 42,04 41,09 41,62 -0,05% 2,27% 386.100
27/06/2005 42,37 42,37 41,49 41,64 -1,42% 2,08% 276.200
24/06/2005 42,51 42,66 41,66 42,24 -1,19% 2,35% 1.469.100
23/06/2005 43,76 43,76 42,55 42,75 -2,06% 2,77% 417.300
22/06/2005 43,33 44,09 43,26 43,65 +1,02% 1,92% 308.600
21/06/2005 42,44 43,22 42,17 43,21 +1,91% 2,47% 515.700
20/06/2005 42,67 43,61 41,98 42,40 -0,56% 3,82% 385.300
17/06/2005 42,82 42,82 41,75 42,64 -0,44% 2,50% 517.600
16/06/2005 39,85 43,43 39,80 42,83 +8,29% 9,11% 1.900.300
15/06/2005 39,48 39,96 39,30 39,55 +0,74% 1,67% 440.200
14/06/2005 39,00 39,40 38,33 39,26 +0,72% 2,74% 546.000
13/06/2005 38,17 39,04 38,10 38,98 +2,26% 2,46% 527.900
10/06/2005 37,02 38,40 37,01 38,12 +1,90% 3,75% 508.000
09/06/2005 36,42 37,41 36,32 37,41 +3,20% 2,99% 435.500
08/06/2005 36,07 36,31 35,76 36,25 +0,69% 1,52% 332.800
07/06/2005 36,70 37,11 35,93 36,00 -1,67% 3,22% 551.500
06/06/2005 37,20 37,47 36,22 36,61 -1,37% 3,36% 348.200
03/06/2005 37,63 37,75 35,70 37,12 -0,83% 5,45% 647.400
02/06/2005 36,87 37,72 36,83 37,43 +1,38% 2,41% 452.700
01/06/2005 37,97 38,02 36,87 36,92 -2,02% 3,03% 610.400
31/05/2005 38,50 38,86 37,61 37,68 -2,28% 3,25% 515.900
27/05/2005 37,46 38,67 37,22 38,56 +3,52% 3,87% 478.400
26/05/2005 37,57 37,69 36,88 37,25 -0,32% 2,16% 315.600
25/05/2005 38,21 38,21 36,81 37,37 -1,97% 3,66% 346.900
24/05/2005 37,20 38,68 37,20 38,12 +2,17% 3,98% 418.800
23/05/2005 36,52 37,54 36,52 37,31 +2,19% 2,79% 549.300